Healthcare expenditures for privately insured US patients with cystic fibrosis, 2010-2016.

ABSTRACT:

Objectives

Published cost estimates for cystic fibrosis (CF) are based on older data and do not reflect increased use of specialty drugs in recent years. We assessed recent trends in healthcare expenditures for CF patients in the United States (US) with employer-sponsored health insurance.

Methods

The study is a retrospective analysis of claims data for privately insured individuals aged 0-64 years who were continuously enrolled in non-capitated plans for at least 1 calendar year during 2010-2016. Mean annual expenditures during a calendar year were calculated for individuals who met a claims-based CF case definition. Average annual growth rates were calculated through linear regression of the natural logarithm of annual expenditures.

Results

The annual CF prevalence

SUBMITTER: Grosse SD 

PROVIDER: S-EPMC6688469 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature